LIPOGEMS ANNOUNCES LAST PATIENT ENROLLED IN THE U.S. FDA IDE ARISE STUDY FOR THE TREATMENT OF KNEE OSTEOARTHRITIS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Lipogems, a clinical stage- global medical technology company, announces it has completed enrollment in the ARISE I U.S. FDA IDE study, which aims to examine Mi
/PRNewswire/ Lipogems, a clinical stage- global medical technology company, announces the first patient enrolled in the ARISE II U.S. FDA IDE research.
LIPOGEMS ANNOUNCES FIRST PATIENT ENROLLED IN THE SECOND U.S. FDA IDE STUDY FOR THE TREATMENT OF KNEE OSTEOARTHRITIS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.